Informações de GSK plc | Histórico, dados financeiros e desempenho de mercado

Mais detalhes de Empresa

Informações da empresa

Código da empresaGSK

Nome da EmpresaGSK plc

Data de listagemMay 22, 1972

CEOMs. Deborah Waterhouse

Número de funcionários68629

Tipo de títulosOrdinary Share

Fim do ano fiscalMay 22

Endereço980 Great West Road

CidadeBRENTFORD

Bolsa de valoresLondon Stock Exchange

PaísUnited Kingdom

Código postalTW8 9GS

Telefone442080475000

Sitehttps://www.gsk.com/

Código da empresaGSK

Data de listagemMay 22, 1972

CEOMs. Deborah Waterhouse

Executivos da empresa

Nome

Nome/Posição

Posição

Ações detidas

Variação

Dr. Hal V. Barron, M.D.

Non-Executive Director

655.20K

+0.04%

Ms. Shobie Ramakrishnan

Chief Digital and Technology Officer

484.20K

+0.09%

Mr. Charles A. (Charlie) Bancroft

Senior Independent Non-Executive Director

38.57K

+5.12%

Ms. Elizabeth McKee (Liz) Anderson

Independent Non-Executive Director

2.98K

+8.76%

Dr. Jeannie Lee

Independent Non-Executive Director and Scientific & Medical Expert

1.56K

+18.05%

Dr. Harry C. (Hal) Dietz

Independent Non-Executive Director, Scientific and Medical Expert

--

Mr. James Ford

Senior Vice President, Group General Counsel, Legal and Compliance

--

Ms. Sally Jackson

Senior Vice President - Global Communications and CEO Office

--

Dr. Tony Wood, Ph.D.

Chief Scientific Officer

--

Ms. Julie Brown

Chief Financial Officer, Executive Director

--

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Dr. Hal V. Barron, M.D.

Non-Executive Director

655.20K

+0.04%

Ms. Shobie Ramakrishnan

Chief Digital and Technology Officer

484.20K

+0.09%

Mr. Charles A. (Charlie) Bancroft

Senior Independent Non-Executive Director

38.57K

+5.12%

Ms. Elizabeth McKee (Liz) Anderson

Independent Non-Executive Director

2.98K

+8.76%

Dr. Jeannie Lee

Independent Non-Executive Director and Scientific & Medical Expert

1.56K

+18.05%

Dr. Harry C. (Hal) Dietz

Independent Non-Executive Director, Scientific and Medical Expert

--

Detalhamento da receita

Moeda: USDAtualizado em: dom, 6 de jul

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Sem dados

Por RegiãoUSD

Nome

Receita

Proporção

US

4.72B

49.92%

Rest of world

2.54B

26.81%

Europe

2.20B

23.27%

Por Empresa

Por Região

Sem dados

Distribuição de ações

Atualizado em: dom, 17 de ago

Investidores

Tipos de investidores

Investidores

Proporção

Dodge & Cox

3.87%

Fidelity Management & Research Company LLC

2.53%

Fisher Investments

1.54%

PRIMECAP Management Company

1.36%

JTC Employer Solutions Trusteee Ltd

0.74%

Outro

89.96%

Investidores

Proporção

Dodge & Cox

3.87%

Fidelity Management & Research Company LLC

2.53%

Fisher Investments

1.54%

PRIMECAP Management Company

1.36%

JTC Employer Solutions Trusteee Ltd

0.74%

Outro

89.96%

Tipos de investidores

Investidores

Proporção

Investment Advisor

9.61%

Investment Advisor/Hedge Fund

7.36%

Research Firm

1.05%

Hedge Fund

0.82%

Bank and Trust

0.11%

Individual Investor

0.06%

Pension Fund

0.06%

Insurance Company

0.05%

Family Office

0.03%

Outro

80.86%

Participação acionária institucional

Atualizado em: ter, 1 de jul

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q2

1478

378.08M

18.54%

+5.70M

2025Q1

1494

378.46M

18.50%

+5.08M

2024Q4

1481

355.06M

17.14%

+27.38M

2024Q3

1472

319.97M

15.44%

-30.07M

2024Q2

1585

322.06M

15.54%

-29.11M

2024Q1

1617

318.91M

15.39%

-23.52M

2023Q4

1614

299.81M

14.57%

-35.71M

2023Q3

1570

293.92M

14.35%

-37.46M

2023Q2

1545

286.58M

13.99%

-41.88M

2023Q1

1546

281.08M

13.72%

-55.01M

Ver Mais

Atividade dos acionistas

Nome

Ações detidas

Proporção

Variação

Var. %

Data

Dodge & Cox

78.65M

3.85%

+10.21M

+14.92%

Mar 31, 2025

Fidelity Management & Research Company LLC

50.60M

2.48%

+6.83M

+15.61%

Mar 31, 2025

Fisher Investments

30.03M

1.47%

+11.20M

+59.43%

Mar 31, 2025

PRIMECAP Management Company

25.71M

1.26%

+446.36K

+1.77%

Mar 31, 2025

JTC Employer Solutions Trusteee Ltd

15.26M

0.75%

-5.02M

-24.75%

Mar 31, 2025

Fidelity Institutional Asset Management

9.52M

0.47%

+465.88K

+5.15%

Mar 31, 2025

T. Rowe Price International Ltd

7.72M

0.38%

+155.40K

+2.05%

Mar 31, 2025

RBC Capital Markets Wealth Management

6.25M

0.31%

+438.49K

+7.54%

Mar 31, 2025

State Street Global Advisors (US)

6.97M

0.34%

-52.09K

-0.74%

Mar 31, 2025

Goldman Sachs Asset Management, L.P.

8.47M

0.41%

-380.46K

-4.30%

Mar 31, 2025

Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de set

Nome

Proporção

VanEck Pharmaceutical ETF

6.11%

USCF Dividend Income Fund

3.98%

The Opal International Dividend Income ETF

3.96%

Keating Active ETF

3.28%

Sound Equity Dividend Income ETF

3.26%

Brandes International ETF

2.84%

GMO International Value ETF

2.18%

Altrius Global Dividend ETF

1.83%

Fidelity Blue Chip Value ETF

1.35%

Fidelity Women's Leadership ETF

1.01%

Ver Mais

VanEck Pharmaceutical ETF

Proporção6.11%

USCF Dividend Income Fund

Proporção3.98%

The Opal International Dividend Income ETF

Proporção3.96%

Keating Active ETF

Proporção3.28%

Sound Equity Dividend Income ETF

Proporção3.26%

Brandes International ETF

Proporção2.84%

GMO International Value ETF

Proporção2.18%

Altrius Global Dividend ETF

Proporção1.83%

Fidelity Blue Chip Value ETF

Proporção1.35%

Fidelity Women's Leadership ETF

Proporção1.01%

Dividendo

Um total de 20.79B USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Feb 05, 2025

GSK.NB Approximate interim Cash Dividend of gross USD 0.400652 paid on Apr 10, 2025 going ex on Feb 21, 2025

Feb 21, 2025

Apr 10, 2025

Feb 21, 2025

Oct 30, 2024

GSK.NB Final Cash Dividend of gross USD 0.376892 paid on Jan 09, 2025 going ex on Nov 15, 2024

Nov 15, 2024

Jan 09, 2025

Nov 15, 2024

Jul 31, 2024

GSK.NB Interim Cash Dividend of gross USD 0.392813 paid on Oct 10, 2024 going ex on Aug 16, 2024

Aug 16, 2024

Oct 10, 2024

Aug 16, 2024

May 01, 2024

GSK.NB Interim Cash Dividend of gross USD 0.384301 paid on Jul 11, 2024 going ex on May 16, 2024

May 17, 2024

Jul 11, 2024

May 16, 2024

Feb 01, 2024

GSK.NB Interim Cash Dividend of gross USD 0.404885 paid on Apr 11, 2024 going ex on Feb 22, 2024

Feb 23, 2024

Apr 11, 2024

Feb 22, 2024

Nov 01, 2023

GSK.NB Final Cash Dividend of gross USD 0.356356 paid on Jan 11, 2024 going ex on Nov 16, 2023

Nov 17, 2023

Jan 11, 2024

Nov 16, 2023

Jul 26, 2023

GSK.NB Interim Cash Dividend of gross USD 0.343532 paid on Oct 12, 2023 going ex on Aug 17, 2023

Aug 18, 2023

Oct 12, 2023

Aug 17, 2023

Apr 26, 2023

GSK.NB Interim Cash Dividend of gross USD 0.360944 paid on Jul 13, 2023 going ex on May 18, 2023

May 19, 2023

Jul 13, 2023

May 18, 2023

Feb 01, 2023

GSK.NB Interim Cash Dividend of gross USD 0.341883 paid on Apr 13, 2023 going ex on Feb 23, 2023

Feb 24, 2023

Apr 13, 2023

Feb 23, 2023

Nov 02, 2022

GSK.NB Final Cash Dividend of gross USD 0.334785 paid on Jan 12, 2023 going ex on Nov 17, 2022

Nov 18, 2022

Jan 12, 2023

Nov 17, 2022

Ver Mais

Desdobramento de ações

Data

Tipo

Proporção

Jun 24, 2022

Merger

5→4

Jun 24, 2022

Merger

5→4

Jun 24, 2022

Merger

5→4

Jun 24, 2022

Merger

5→4

Data

Tipo

Proporção

Jun 24, 2022

Merger

5→4

Jun 24, 2022

Merger

5→4

Jun 24, 2022

Merger

5→4

Jun 24, 2022

Merger

5→4

GSK plc

39.850USD

GSK plc

39.850

Visão Geral

Empresa

Serviços Financeiros

Análises